myirislogo
21 October, 2019 11:23 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
Tata Motors 136.70 1.05
State Bank O 269.65 1.58
Tata Stl 359.90 1.19
Tata Power 60.05 0.42
Reliance 1415.30 1.37
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Orchid Pharma Limited
Orchid Pharma Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:24372NSE:ORCHIDPHARBloomberg:OCP@INReuters:ORCD.BO
Market Lot: 1Face Value: 10ISIN Demat: INE191A01019
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
12-JUN-18 Orchid Pharma has received a EU GMP (Good Manufacturing Practice) certification on its APl manufacturing facility located at SlDCO Industrial Estate, Alathur, Kancheepuram. 24-MAY-17 Orchid Pharma has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (USFDA) for Aripiprazole tablets USP, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg on May 24, 2017. 18-APR-17 Orchid Pharma has receive...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Orchid Pharma gets ANDA clearance for Aripiprazole tablets  -IRIS 24-May-17
Previous

 


Brief Financials (in Rs. Mn.)Detailed Quarterly
Period ending (months)31-Mar-2016(6)30-Sep-2015(12)30-Sep-2014(12)
Net sales 4055.539025.2312707.11
Other Income91.580.817.68
Total Income4147.119026.0412714.79
Cost of goods sold3254.967195.9210370.87
OPBDIT892.151830.122343.92
PAT-1577.67-3846.49771.03
Gross Block---
Equity capital889.64852.62704.52
EPS (Rs.)---
DPS (Rs.)---
BV (Rs.)---
P/E range (x)---
Debt / Equity (x)---
Operating margin (% of OI)21.520.318.4
Net margin (% of OI)-38.0-42.6 6.1
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Orchid Towers
313, Valluvar Kottam High Road
Nungambakkam
Chennai
Tamil Nadu-600 034
PHONE
(044) 2821 1000
FAX
(044) 2821 1002
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer